Abstract:Pancreatic adenocarcinoma (PAAD) is the fourth leading cause of tumor-related deaths in the United States. [ 1 ] The incidence of PAAD is increasing by 0.5% to 1.0% per year and is projected to become the second leading cause of cancer-related mortality by 2030. [ 2 , 3 ] The average survival time for patients with PAAD is less than 6 months, and the overall 5-year survival rate for patients who undergo surgical resection is only 10% to 25%. [ 4 ] However, predicting the prognosis of PAAD is challenging because of the high heterogeneity in the tumor microenvironment and complex risk factors. Therefore, it is important to identify the prognostic signature and associated mechanisms of PAAD.

Integrated analysis identifies cuproptosis-related gene DLAT and its competing endogenous RNAs network to predict the prognosis of pancreatic adenocarcinoma patients